secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001773751-22-000030
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q4 revenue $84.7M (+104% YoY); FY2021 revenue $271.9M; guides FY2022 rev $365-380M
--------------------------------------------------------------------------------

- Q4 2021 revenue $84.7M (+104% YoY); net loss $(31.2)M vs $(5.2)M loss in Q4 2020.
- Full year 2021 revenue $271.9M (+83% YoY); net loss $(107.7)M vs $(18.1)M.
- Subscriptions at 609,000, up 95% YoY; gross margin 73% in Q4 vs 77% a year ago.
- Provides Q1 and FY2022 guidance: FY2022 revenue $365-380M; Adj EBITDA $(30)M to $(20)M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000030/0001773751-22-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375122000030/hims-20220222.htm
  HTML page:      https://secwatch.observer/filing/0001773751-22-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer